| Deedee Marlene Love, | |
|
3800 S Ocean Dr Ste 209, Hollywood, FL 33019-2915 | |
| (800) 226-8874 | |
| (877) 366-4776 |
| Full Name | Deedee Marlene Love |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 3800 S Ocean Dr Ste 209, Hollywood, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013502970 | NPI | - | NPPES |
| 113554800 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APRN11007503 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Qsm-fl, Inc | 0648548982 | 18 |
| Quality Surgical Management Inc | 8921196403 | 3 |
| Qsm-ga, Inc | 3779842729 | 11 |
News Archive
When girls reach puberty at an unusually early age, they face a significantly higher risk of developing breast cancer later in life. Now, experts at Cincinnati Children's and the University of Cincinnati offer a new, unified explanation for why that increased risk occurs.
Coagulation tests are warranted in young women undergoing surgery for subclavian vein thrombosis, especially patients with Paget-Schroetter syndrome unrelated to physical activity, say US clinicians.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that it has reached the enrollment goal of 325 patients for its Phase 2b dose-ranging clinical trial of XOMA 052, and that it expects patient enrollment to close in July 2010, with top-line results available in the first quarter of 2011. XOMA 052 is a therapeutic antibody candidate that inhibits the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) which drives the inflammatory cause of Type 2 diabetes.
Even in Florida, where Republican leaders led the legal battle against Obamacare, there's recognition now that the state has to act fast to comply with the new law. ... After Nov. 6, Gov. Rick Scott had a change in tone. "Gov. Mitt Romney did not win the election. So, it's not an option to repeal Obamacare," he said. "So, my goal now is to focus on what's good for our citizens." But Republicans are having trouble convincing Tea Party activists that the fight is over.
The U.S. Food and Drug Administration today approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra already is approved for use in people ages 2 through 55 years.
› Verified 2 days ago
| Entity Name | Quality Surgical Management Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376758904 PECOS PAC ID: 8921196403 Enrollment ID: O20080423000469 |
News Archive
When girls reach puberty at an unusually early age, they face a significantly higher risk of developing breast cancer later in life. Now, experts at Cincinnati Children's and the University of Cincinnati offer a new, unified explanation for why that increased risk occurs.
Coagulation tests are warranted in young women undergoing surgery for subclavian vein thrombosis, especially patients with Paget-Schroetter syndrome unrelated to physical activity, say US clinicians.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that it has reached the enrollment goal of 325 patients for its Phase 2b dose-ranging clinical trial of XOMA 052, and that it expects patient enrollment to close in July 2010, with top-line results available in the first quarter of 2011. XOMA 052 is a therapeutic antibody candidate that inhibits the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) which drives the inflammatory cause of Type 2 diabetes.
Even in Florida, where Republican leaders led the legal battle against Obamacare, there's recognition now that the state has to act fast to comply with the new law. ... After Nov. 6, Gov. Rick Scott had a change in tone. "Gov. Mitt Romney did not win the election. So, it's not an option to repeal Obamacare," he said. "So, my goal now is to focus on what's good for our citizens." But Republicans are having trouble convincing Tea Party activists that the fight is over.
The U.S. Food and Drug Administration today approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra already is approved for use in people ages 2 through 55 years.
› Verified 2 days ago
| Entity Name | Qsm-fl, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609318617 PECOS PAC ID: 0648548982 Enrollment ID: O20170609001771 |
News Archive
When girls reach puberty at an unusually early age, they face a significantly higher risk of developing breast cancer later in life. Now, experts at Cincinnati Children's and the University of Cincinnati offer a new, unified explanation for why that increased risk occurs.
Coagulation tests are warranted in young women undergoing surgery for subclavian vein thrombosis, especially patients with Paget-Schroetter syndrome unrelated to physical activity, say US clinicians.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that it has reached the enrollment goal of 325 patients for its Phase 2b dose-ranging clinical trial of XOMA 052, and that it expects patient enrollment to close in July 2010, with top-line results available in the first quarter of 2011. XOMA 052 is a therapeutic antibody candidate that inhibits the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) which drives the inflammatory cause of Type 2 diabetes.
Even in Florida, where Republican leaders led the legal battle against Obamacare, there's recognition now that the state has to act fast to comply with the new law. ... After Nov. 6, Gov. Rick Scott had a change in tone. "Gov. Mitt Romney did not win the election. So, it's not an option to repeal Obamacare," he said. "So, my goal now is to focus on what's good for our citizens." But Republicans are having trouble convincing Tea Party activists that the fight is over.
The U.S. Food and Drug Administration today approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra already is approved for use in people ages 2 through 55 years.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deedee Marlene Love, 3800 S Ocean Dr Ste 209, Hollywood, FL 33019-2915 Ph: (008) 226-8874 | Deedee Marlene Love, 3800 S Ocean Dr Ste 209, Hollywood, FL 33019-2915 Ph: (800) 226-8874 |
News Archive
When girls reach puberty at an unusually early age, they face a significantly higher risk of developing breast cancer later in life. Now, experts at Cincinnati Children's and the University of Cincinnati offer a new, unified explanation for why that increased risk occurs.
Coagulation tests are warranted in young women undergoing surgery for subclavian vein thrombosis, especially patients with Paget-Schroetter syndrome unrelated to physical activity, say US clinicians.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that it has reached the enrollment goal of 325 patients for its Phase 2b dose-ranging clinical trial of XOMA 052, and that it expects patient enrollment to close in July 2010, with top-line results available in the first quarter of 2011. XOMA 052 is a therapeutic antibody candidate that inhibits the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) which drives the inflammatory cause of Type 2 diabetes.
Even in Florida, where Republican leaders led the legal battle against Obamacare, there's recognition now that the state has to act fast to comply with the new law. ... After Nov. 6, Gov. Rick Scott had a change in tone. "Gov. Mitt Romney did not win the election. So, it's not an option to repeal Obamacare," he said. "So, my goal now is to focus on what's good for our citizens." But Republicans are having trouble convincing Tea Party activists that the fight is over.
The U.S. Food and Drug Administration today approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra already is approved for use in people ages 2 through 55 years.
› Verified 2 days ago
Fiorella Jahaira Saka, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1150 N 35th Ave, Suite 590, Hollywood, FL 33021 Phone: 954-265-9500 Fax: 954-265-1431 | |
Bella Gleiser Mendez, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1150 N 35th Ave Ste 385, Hollywood, FL 33021 Phone: 954-265-4325 | |
Andrea Annmarie Goulbourne-smith, APRN, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7369 Sheridan St Ste 101, Hollywood, FL 33024 Phone: 954-561-6222 Fax: 954-990-7650 | |
Roberto Santamaria, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1957 Jackson St, Hollywood, FL 33020 Phone: 954-921-2600 | |
Jennifer Aphrodite Germain, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1920 N 53rd Ave, Hollywood, FL 33021 Phone: 305-450-8698 | |
Linda C Barreras, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 750 S Federal Hwy, Hollywood, FL 33020 Phone: 954-342-8800 Fax: 954-342-8700 | |
Mrs. Christine M Browne, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 200 S Park Rd Ste 200, Hollywood, FL 33021 Phone: 954-923-7440 Fax: 954-923-1299 |